medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Número 3

<< Anterior Siguiente >>

Rev Invest Clin 2016; 68 (3)


Clinical benefit of 3 Tesla magnetic resonance imaging rescanning in patients with focal epilepsy and negative 1.5 tesla magnetic resonance imaging

Ladino LD, Balaguera P, Rascovsky S, Delgado J, Llano J, Hernández-Ronquillo L, Gómez-Arias B, Téllez-Zenteno JF

Idioma: Ingles.
Referencias bibliográficas: 25
Paginas: 112-118
Archivo PDF: 169.75 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lüders HO, Najm I, Nair D, Widdess-Walsh P, Bingman W. The epileptogenic zone: general principles. Epileptic Disord. 2006; 8(Suppl 2):S1-9.

  2. Duncan JS. Imaging in the surgical treatment of epilepsy. Nat Rev Neurol. 2010;6:537-50.

  3. Craven IJ, Griffiths PD, Bhattacharyya D, et al. 3.0 T MRI of 2000 consecutive patients with localisation-related epilepsy. Br J Radiol. 2012;85:1236-42.

  4. Téllez-Zenteno JF, Hernández Ronquillo L, Moien-Afshari F, Wiebe S. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2010;89:310-18.

  5. Griffiths PD, Coley SC, Connolly DJ, et al. MR imaging of patients with localisation-related seizures: initial experience at 3.0T and relevance to the NICE guidelines. Clin Radiol. 2005;60:1090-99.

  6. Friedman E. Epilepsy imaging in adults: getting it right. AJR Am J Roentgenol. 2014;203:1093-103.

  7. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia. 1989;30: 389-99.

  8. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069-77.

  9. Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med. 2011;365:919-26.

  10. Shah AK, Mittal S. Evaluation of magnetic resonance imagingnegative drug-resistant epilepsy. Ann Indian Acad Neurol. 2014; 17(Suppl 1):S80-8.

  11. Avrahami E, Cohn DF, Neufeld M, et al. Magnetic resonance imaging (MRI) in patients with complex partial seizures and normal computerized tomography (CT) scan. Clin Neurol Neurosurg. 1987;89:231-5.

  12. Jabbari B, Gunderson CH, Wippold F, et al. Magnetic resonance imaging in partial complex epilepsy. Arch Neurol. 1986;43: 869-72.

  13. Knake S, Triantafyllou C, Wald LL, et al. 3T phased array MRI improves the presurgical evaluation in focal epilepsies: a prospective study. Neurology. 2005;65:1026-31.

  14. Orbach DB, Wu C, Law M, et al. Comparing real-world advantages for the clinical neuroradiologist between a high field (3 T), a phased array (1.5 T) vs. a single-channel 1.5-T MR system. J Magn Reson Imaging. 2006;24:16-24.

  15. von Oertzen J, Urbach H, Jungbluth S, Kurthen M, Reuber M, Fernández G, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002;73:643-7.

  16. Goyal M, Bangert BA, Lewin JS, Cohen ML, Robinson S. Highresolution MRI enhances identification of lesions amenable to surgical therapy in children with intractable epilepsy. Epilepsia. 2004;45:954-9.

  17. Winston GP, Micallef C, Kendell BE, et al. The value of repeat neuroimaging for epilepsy at a tertiary referral centre: 16 years of experience. Epilepsy Res. 2013;105:349-55.

  18. Zijlmans M, de Kort GA, Witkamp TD, et al. 3T versus 1.5T phased-array MRI in the presurgical work-up of patients with partial epilepsy of uncertain focus. J Magn Reson Imaging. 2009; 30:256-62.

  19. Mellerio C, Labeyrie MA, Chassoux F, et al. 3T MRI improves the detection of transmantle sign in type 2 focal cortical dysplasia. Epilepsia. 2014;55:117-22.

  20. Strandberg M, Larsson EM, Backman S, Källén K. Pre-surgical epilepsy evaluation using 3T MRI. Do surface coils provide additional information? Epileptic Disord. 2008;10:83-92.

  21. Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain. 2002;125:1719-32.

  22. McBride MC, Bronstein KS, Bennett B, Erba G, Pilcher W, Berg MJ. Failure of standard magnetic resonance imaging in patients with refractory temporal lobe epilepsy. Arch Neurol. 1998;55: 346-8.

  23. Nguyen DK, Rochette E, Leroux JM, et al. Value of 3.0 T MR imaging in refractory partial epilepsy and negative 1.5 T MRI. Seizure. 2010;19:475-8.

  24. Seeck M. Epilepsy: Repeat MRI in patients with chronic epilepsy. Nat Rev Neurol. 2013;9:545-6.

  25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74.




2020     |     www.medigraphic.com